Table S2

Narges Alipanah-Lechner, Lucile Neyton, Eran Mick, Andrew Willmore, Aleksandra Leligdowicz, Kevin Contrepois, Alejandra Jauregui, Hanjing Zhuo, Carolyn Hendrickson, Antonio Gomez, Pratik Sinha, Kirsten N. Kangelaris, Kathleen D. Liu, Michael A Matthay & Carolyn S. Calfee
Metabolites differentially abundant in the hyperinflammatory ARDS phenotype compared to the hypoinflammatory phenotype. Metabolites listed in the order of increasing log2 fold change. Analyses adjusted for age, sex, propofol, dexmedetomidine, and liver and kidney disease.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.